Immutep (IMMP) Non-cash Items (2023)

Immutep (IMMP) posted Non-cash Items of $19.6 million for Q4 2023, down 2.72% on a QoQ basis from $20.1 million in Q2 2023.

Immutep (IMMP) Non-cash Items (2023) Analysis & Trends

Immutep's Non-cash Items history runs 1 years deep, the most recent figure standing at $19.6 million for Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn
7	Belite Bio	61.40 Bn	61.40 Bn	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn
9	Revolution Medicines	37.37 Bn	37.37 Bn	-
10	Immutep	569.08 Mn	569.08 Mn	-

Download Data